Skip to Main Content

Author Details

Stephan C Sch??rer
Institute for Data Science and Computing, University of Miami
1998
125
37
PMIDPaper TitleJournal TitlePublished Year
36202365Predicting COVID-19 cases using SARS-CoV-2 RNA in air, surface swab and wastewater samples.Sci Total Environ2023
36202365Predicting COVID-19 cases using SARS-CoV-2 RNA in air, surface swab and wastewater samples.Sci Total Environ2023
37732296Smoking induces WEE1 expression to promote docetaxel resistance in esophageal adenocarcinoma.Mol Ther Oncolytics2023
37649813Correction: The Genetic Landscape of Ocular Adnexa MALT Lymphoma Reveals Frequent Aberrations in NFAT and MEF2B Signaling Pathways.Cancer Res Commun2023
37568227An extension of the BioAssay Ontology to include pharmacokinetic/pharmacodynamic terminology for the enrichment of scientific workflows.J Biomed Semantics2023
37216988Monkeypox viral nucleic acids detected using both DNA and RNA extraction workflows.Sci Total Environ2023
36624666Pharos 2023: an integrated resource for the understudied human proteome.Nucleic Acids Res2023
36623667Degradation rates influence the ability of composite samples to represent 24-hourly means of SARS-CoV-2 and other microbiological target measures in wastewater.Sci Total Environ2023
36938545A novel chemical attack on Notch-mediated transcription by targeting the NACK ATPase.Mol Ther Oncolytics2023
37235579AI-Assisted chemical probe discovery for the understudied Calcium-Calmodulin Dependent Kinase, PNCK.PLoS Comput Biol2023
36862086Reversal of Lactate and PD-1-mediated Macrophage Immunosuppression Controls Growth of PTEN/p53-deficient Prostate Cancer.Clin Cancer Res2023
37541199Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer.Cell2023
37649813Correction: The Genetic Landscape of Ocular Adnexa MALT Lymphoma Reveals Frequent Aberrations in NFAT and MEF2B Signaling Pathways.Cancer Res Commun2023
37541199Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer.Cell2023
37732296Smoking induces WEE1 expression to promote docetaxel resistance in esophageal adenocarcinoma.Mol Ther Oncolytics2023
37568227An extension of the BioAssay Ontology to include pharmacokinetic/pharmacodynamic terminology for the enrichment of scientific workflows.J Biomed Semantics2023
37216988Monkeypox viral nucleic acids detected using both DNA and RNA extraction workflows.Sci Total Environ2023
37235579AI-Assisted chemical probe discovery for the understudied Calcium-Calmodulin Dependent Kinase, PNCK.PLoS Comput Biol2023
36624666Pharos 2023: an integrated resource for the understudied human proteome.Nucleic Acids Res2023
36623667Degradation rates influence the ability of composite samples to represent 24-hourly means of SARS-CoV-2 and other microbiological target measures in wastewater.Sci Total Environ2023
36938545A novel chemical attack on Notch-mediated transcription by targeting the NACK ATPase.Mol Ther Oncolytics2023
36862086Reversal of Lactate and PD-1-mediated Macrophage Immunosuppression Controls Growth of PTEN/p53-deficient Prostate Cancer.Clin Cancer Res2023
34735897A novel strategy for combination of clofarabine and pictilisib is synergistic in gastric cancer.Transl Oncol2022
35524556SigCom LINCS: data and metadata search engine for a million gene expression signatures.Nucleic Acids Res2022
35945222Connecting omics signatures and revealing biological mechanisms with iLINCS.Nat Commun2022
36207580A multi-omic analysis of MCF10A cells provides a resource for integrative assessment of ligand-mediated molecular and phenotypic responses.Commun Biol2022
36398131Relationships between SARS-CoV-2 in Wastewater and COVID-19 Clinical Cases and Hospitalizations, with and without Normalization against Indicators of Human Waste.ACS ES T Water2022
37601294Comparison of Electronegative Filtration to Magnetic Bead-Based Concentration and V2G-qPCR to RT-qPCR for Quantifying Viral SARS-CoV-2 RNA from Wastewater.ACS ES T Water2022
36465101Cellular and molecular effects of PNCK, a non-canonical kinase target in renal cell carcinoma.iScience2022
34735897A novel strategy for combination of clofarabine and pictilisib is synergistic in gastric cancer.Transl Oncol2022
35058449Proteomic cellular signatures of kinase inhibitor-induced cardiotoxicity.Sci Data2022
37601294Comparison of Electronegative Filtration to Magnetic Bead-Based Concentration and V2G-qPCR to RT-qPCR for Quantifying Viral SARS-CoV-2 RNA from Wastewater.ACS ES T Water2022
35524556SigCom LINCS: data and metadata search engine for a million gene expression signatures.Nucleic Acids Res2022
36398131Relationships between SARS-CoV-2 in Wastewater and COVID-19 Clinical Cases and Hospitalizations, with and without Normalization against Indicators of Human Waste.ACS ES T Water2022
36465101Cellular and molecular effects of PNCK, a non-canonical kinase target in renal cell carcinoma.iScience2022
36207580A multi-omic analysis of MCF10A cells provides a resource for integrative assessment of ligand-mediated molecular and phenotypic responses.Commun Biol2022
35945222Connecting omics signatures and revealing biological mechanisms with iLINCS.Nat Commun2022
35058449Proteomic cellular signatures of kinase inhibitor-induced cardiotoxicity.Sci Data2022
33156327TCRD and Pharos 2021: mining the human proteome for disease biology.Nucleic Acids Res2021
35528192The Genetic Landscape of Ocular Adnexa MALT Lymphoma Reveals Frequent Aberrations in NFAT and MEF2B Signaling Pathways.Cancer Res Commun2021
31904426Machine and deep learning approaches for cancer drug repurposing.Semin Cancer Biol2021
33577785Proteogenomic and metabolomic characterization of human glioblastoma.Cancer Cell2021
33932279Predictors of Clinical Outcome After Early Veno-Arterial Extracorporeal Membrane Oxygenation in Cardiogenic Shock Complicating ST-Elevation Myocardial Infarction.J Invasive Cardiol2021
33156327TCRD and Pharos 2021: mining the human proteome for disease biology.Nucleic Acids Res2021
34739849A library of induced pluripotent stem cells from clinically well-characterized, diverse healthy human individuals.Stem Cell Reports2021
34676755Discovery of an eIF4A Inhibitor with a Novel Mechanism of Action.J Med Chem2021
35118385A multiparametric pharmacogenomic strategy for drug repositioning predicts therapeutic efficacy for glioblastoma cell lines.Neurooncol Adv2021
34375259Lessons learned from SARS-CoV-2 measurements in wastewater.Sci Total Environ2021
35136384Loop-Mediated Isothermal Amplification Detection of SARS-CoV-2 and Myriad Other Applications.J Biomol Tech2021
35528192The Genetic Landscape of Ocular Adnexa MALT Lymphoma Reveals Frequent Aberrations in NFAT and MEF2B Signaling Pathways.Cancer Res Commun2021
  • 1 - 50 of 250

Recommended Authors

Wail Ba-Alawi
Princess Margaret Cancer Centre, University Health Network, University Ave.
Career Start Year 2013
Number of shared co-authors 0
Shraddha Thakkar
Center for Drug Evaluations and Research (CDER)
Career Start Year 2013
Number of shared co-authors 3
Minjae Yoo
University of Colorado Anschutz Medical Campus
Career Start Year 2011
Number of shared co-authors 1
Nehme El-Hachem
Centre Hospitalier Universitaire Sainte-Justine Research Centre
Career Start Year 2011
Number of shared co-authors 0
Sam Michael
National Center for Advancing Translational Sciences, National Institutes of Health
Career Start Year 2008
Number of shared co-authors 8
Wenwei Lin
St. Jude Children's Research Hospital
Career Start Year 2007
Number of shared co-authors 1
Michael J Keiser
Institute for Neurodegenerative Diseases, University of California san francisco
Career Start Year 2007
Number of shared co-authors 4
Andrew T Magis
Institute for Systems Biology
Career Start Year 2007
Number of shared co-authors 0
Jing Tang
University of Helsinki
Career Start Year 2007
Number of shared co-authors 4
Ola Spjuth
Department of Pharmaceutical Biosciences, Uppsala University
Career Start Year 2006
Number of shared co-authors 4
Sanjay J Swamidass
Washington University School of Medicine
Career Start Year 2005
Number of shared co-authors 6
Michael Hsing
University of British Columbia
Career Start Year 2004
Number of shared co-authors 0
Julio Saez-Rodriguez
Institute of Computational Biomedicine, Heidelberg University
Career Start Year 2004
Number of shared co-authors 11
Anang A Shelat
St. Jude Children's Research Hospital
Career Start Year 2003
Number of shared co-authors 6
Gerald H Lushington
Inc. 16 Dekalb Pike
Career Start Year 2002
Number of shared co-authors 0
William H Bisson
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 2001
Number of shared co-authors 1
Tero Aittokallio
Institute for Molecular Medicine Finland (FIMM), University of Helsinki
Career Start Year 1999
Number of shared co-authors 11
Yingyao Zhou
Genomics Institute of the Novartis Research Foundation
Career Start Year 1997
Number of shared co-authors 2
Bissan Al-Lazikani
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 5
Vlado Dan????k
Broad Institute
Career Start Year 1997
Number of shared co-authors 9
Peter Kolb
Institut fur Pharmazeutische Chemie, Philipps-Universitat Marburg
Career Start Year 1996
Number of shared co-authors 2
Niklas Blomberg
Universitat Tubingen, Institut fur Arbeitsmedizin
Career Start Year 1996
Number of shared co-authors 10
Andrew L Hopkins
University of Dundee
Career Start Year 1995
Number of shared co-authors 5
David de Graaf
Syntimmune Inc.
Career Start Year 1995
Number of shared co-authors 1
Jeremy S Caldwell
Sirna Therapeutics a former subsidiary of Merck & Co., Inc.
Career Start Year 1994
Number of shared co-authors 1
Zhuyin Li
National Center for Advancing Translational Sciences, National Institutes of Health
Career Start Year 1994
Number of shared co-authors 2
Michael Ohlmeyer
Atux Iskay LLC
Career Start Year 1993
Number of shared co-authors 4
Marc Ferrer
National Institutes of Health, National Center for Advancing Translational Sciences
Career Start Year 1992
Number of shared co-authors 6
Stefan Knapp
Institute of Pharmaceutical Chemistry, Goethe University
Career Start Year 1983
Number of shared co-authors 9
Russ B Altman
Stanford University
Career Start Year 1982
Number of shared co-authors 8

Collaborators

Dušica VidoviĿ
Co-authored papers 37
Vasileios Stathias
Co-authored papers 21
Caty Chung
Co-authored papers 17
Avi Ma'ayan
Icahn School of Medicine at Mount Sinai
Co-authored papers 13
Amar Koleti
Co-authored papers 11
Tudor I Oprea
Expert Systems Inc.
Co-authored papers 10
Nagi G Ayad
Co-authored papers 10
Jeremy J Yang
Co-authored papers 10
Uma D Vempati
Miller School of Medicine Miami, University of Miami
Co-authored papers 9
Dac-Trung Nguyen
Co-authored papers 8
Daniel J Cooper
Miller School of Medicine, University of Miami
Co-authored papers 8
Stephen L Mathias
Co-authored papers 8
Cristian G Bologa
University of New Mexico School of Medicine
Co-authored papers 8
Noel Southall
National Center for Advancing Translational Sciences, National Institutes of Health
Co-authored papers 7
Lars Juhl Jensen
Novo Nordisk Foundation Center for Protein Research, University of Copenhagen
Co-authored papers 7
Arya Ajay
National Center for Advancing Translational Science, 9800 Medical Center Drive
Co-authored papers 7
Rajarshi Guha
Vertex Pharmaceuticals
Co-authored papers 7
Anna Waller
Co-authored papers 6
Raymond Terryn
Co-authored papers 6
Kathleen M Jagodnik
Massachusetts General Hospital Department of Psychiatry, Harvard Medical School.
Co-authored papers 6
Mario Medvedovic
Co-authored papers 6
Jayme Holmes
Co-authored papers 6
Oleg Ursu
Co-authored papers 6
Vance P Lemmon
Co-authored papers 5
Daniel J B Clarke
Icahn School of Medicine at Mount Sinai
Co-authored papers 5
Michele Forlin
Co-authored papers 5
Francisco Vega
The University of Texas MD Anderson Cancer Center
Co-authored papers 5
Sherry L Jenkins
Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
Co-authored papers 5
Denis Torre
Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
Co-authored papers 5
Christopher C Mader
Co-authored papers 5
Release 1.2